A CD45‐based barcoding approach to multiplex mass‐cytometry (CyTOF)

CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐D...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 87; no. 4; pp. 369 - 374
Main Authors Lai, Liyun, Ong, Raymond, Li, Juntao, Albani, Salvatore
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Ltd 01.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐DOTA) provide a very useful tool. However, using m‐DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m‐DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra‐ and intra‐cellular targets. We show here that our approach provides an useful alternative to m‐DOTA in terms of sensitivity, specificity, flexibility, and user‐friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). © 2015 The Authors. Published by Wiley Periodicals, Inc.
AbstractList CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). copyright 2015 The Authors. Published by Wiley Periodicals, Inc.
CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido‐monoamide‐DOTA (m‐DOTA) provide a very useful tool. However, using m‐DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m‐DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra‐ and intra‐cellular targets. We show here that our approach provides an useful alternative to m‐DOTA in terms of sensitivity, specificity, flexibility, and user‐friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples). © 2015 The Authors. Published by Wiley Periodicals, Inc.
CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples).
CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples).CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples).
Author Lai, Liyun
Ong, Raymond
Albani, Salvatore
Li, Juntao
Author_xml – sequence: 1
  givenname: Liyun
  surname: Lai
  fullname: Lai, Liyun
  organization: Singapore Health Services Pte Ltd
– sequence: 2
  givenname: Raymond
  surname: Ong
  fullname: Ong, Raymond
  organization: Singapore Health Services Pte Ltd
– sequence: 3
  givenname: Juntao
  surname: Li
  fullname: Li, Juntao
  organization: Singapore Health Services Pte Ltd
– sequence: 4
  givenname: Salvatore
  surname: Albani
  fullname: Albani, Salvatore
  organization: Duke‐NUS Graduate Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25645694$$D View this record in MEDLINE/PubMed
BookMark eNqNkctq3DAUhkVIya3ddV28TCEz0d2jTWFwboXAbKaLrsSRrElUbMuVPG29yyPkGfMktTvJkAYaujoHzvf_53aIdpvQOITeEzwlGNNT23dhClNKJcc76IAIQSdcMby7zSndR4cpfcOYCczoHtqnQnIhFT9Al_OsOOPi4e7eQHJlZiDaUPrmJoO2jQHsbdaFrF5XnW8r9yurIaUBHpvWrot9dlz0y8XFx7fozQqq5N49xiP05eJ8WVxNrheXn4v59cQKOsMTia1lymLqSmlBGsnUqhSGqBWGmXEUSskpkVwyVkqQJTeGcEmUIfkMc-DsCH3a-LZrU7vSuqaLUOk2-hpirwN4_Xel8bf6JvzQXOZYKjUYHD8axPB97VKna5-sqypoXFgnTWTO2IzkIv8PdGB5rsTo-uH5WNt5ng49ACcbwMaQUnSrLUKwHv-ox5Nq0H_-OOD0BW59B50P41K--peIb0Q_feX6Vxvo4utyMd_IfgO88bOF
CitedBy_id crossref_primary_10_1177_2472630319834057
crossref_primary_10_4049_jimmunol_1600727
crossref_primary_10_3389_fimmu_2020_615091
crossref_primary_10_1016_j_cell_2021_04_039
crossref_primary_10_1038_s41385_021_00469_5
crossref_primary_10_1038_nprot_2017_155
crossref_primary_10_1002_cyto_a_23621
crossref_primary_10_1136_gutjnl_2017_315485
crossref_primary_10_4155_bio_15_257
crossref_primary_10_1002_eji_201970107
crossref_primary_10_1038_s41598_021_91816_w
crossref_primary_10_1016_j_csbj_2020_03_024
crossref_primary_10_1038_s41598_020_70492_2
crossref_primary_10_1016_j_csbj_2021_05_032
crossref_primary_10_1016_j_xpro_2022_101697
crossref_primary_10_3389_fimmu_2020_578176
crossref_primary_10_1155_2019_6705949
crossref_primary_10_1016_j_jacc_2018_08_2148
crossref_primary_10_1038_s41569_021_00589_2
crossref_primary_10_3389_fimmu_2020_01602
crossref_primary_10_1186_s13059_018_1603_1
crossref_primary_10_7554_eLife_79016
crossref_primary_10_1002_cyto_a_23014
crossref_primary_10_1002_cyto_a_24543
crossref_primary_10_1038_s41598_017_03610_2
crossref_primary_10_1136_jitc_2022_004717
crossref_primary_10_1002_cyto_a_24308
crossref_primary_10_1002_eji_201646632
crossref_primary_10_1371_journal_pone_0194593
crossref_primary_10_1038_s41584_019_0338_z
crossref_primary_10_1038_s41467_022_29122_w
crossref_primary_10_1172_jci_insight_143283
crossref_primary_10_3389_fimmu_2023_1182016
crossref_primary_10_1016_j_jid_2017_02_006
crossref_primary_10_1002_cyto_a_24907
crossref_primary_10_3389_fimmu_2021_674279
crossref_primary_10_1021_acs_analchem_1c03442
crossref_primary_10_1016_j_canlet_2022_215977
crossref_primary_10_1021_acs_chemrev_2c00350
crossref_primary_10_1002_cyto_a_23283
crossref_primary_10_3390_cancers14081861
crossref_primary_10_1002_cyto_a_22992
crossref_primary_10_1038_s41598_018_28791_2
crossref_primary_10_1016_j_ccell_2019_01_003
crossref_primary_10_1136_gutjnl_2018_316510
crossref_primary_10_3389_fgene_2022_1057302
crossref_primary_10_3390_cancers13215440
crossref_primary_10_1136_annrheumdis_2019_216059
crossref_primary_10_1158_1078_0432_CCR_18_4011
crossref_primary_10_1097_HC9_0000000000000508
crossref_primary_10_1038_s41591_019_0590_4
crossref_primary_10_1002_cyto_a_22876
crossref_primary_10_1016_j_ymeth_2024_11_014
crossref_primary_10_4155_bio_2016_0135
crossref_primary_10_1002_cyto_a_22717
crossref_primary_10_1073_pnas_1806695115
crossref_primary_10_1002_cyto_a_23034
crossref_primary_10_1002_eji_202048857
crossref_primary_10_1073_pnas_1706559114
crossref_primary_10_1016_j_cej_2024_154118
crossref_primary_10_1021_acs_analchem_8b03201
crossref_primary_10_1002_cyto_a_23919
Cites_doi 10.1016/j.it.2012.02.010
10.1038/nmeth872
10.1002/cyto.a.22060
10.1038/nbt.2317
10.1007/s00262-013-1416-8
10.1021/bm201011t
10.1002/0471142956.cy0631s55
10.1126/science.1198704
10.1080/1042819031000151932
ContentType Journal Article
Copyright 2015 The Authors. Published by Wiley Periodicals, Inc.
2015 The Authors. Published by Wiley Periodicals, Inc. 2015
Copyright_xml – notice: 2015 The Authors. Published by Wiley Periodicals, Inc.
– notice: 2015 The Authors. Published by Wiley Periodicals, Inc. 2015
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QO
8FD
FR3
P64
5PM
DOI 10.1002/cyto.a.22640
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Engineering Research Database

CrossRef
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1552-4930
EndPage 374
ExternalDocumentID PMC4670699
25645694
10_1002_cyto_a_22640
CYTOA22640
Genre article
Journal Article
GrantInformation_xml – fundername: National Medical Research Council, Singapore (NMRC reference number NMRC/STaR/020/2013)
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
2WC
31~
33P
3SF
4.4
4ZD
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABPVW
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CO8
CS3
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRSTM
DU5
E3Z
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
P2P
P2W
P2X
P4D
Q.N
QB0
QRW
R.K
RNS
ROL
RWI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WIH
WIK
WIN
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XV2
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
7QO
8FD
FR3
P64
5PM
ID FETCH-LOGICAL-c5280-60cc39c02ed6ca6b639fd5b19f0a8be2ad642164633d6a6d4bb14619b17804a43
IEDL.DBID DR2
ISSN 1552-4922
1552-4930
IngestDate Thu Aug 21 18:23:14 EDT 2025
Fri Jul 11 09:28:07 EDT 2025
Fri Jul 11 04:54:11 EDT 2025
Thu Apr 03 07:02:40 EDT 2025
Tue Jul 01 00:49:15 EDT 2025
Thu Apr 24 22:58:26 EDT 2025
Wed Jan 22 16:55:22 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords barcoding
multiplexing
CD45
CyTOF
Language English
License Attribution-NonCommercial
http://creativecommons.org/licenses/by-nc/4.0
2015 The Authors. Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5280-60cc39c02ed6ca6b639fd5b19f0a8be2ad642164633d6a6d4bb14619b17804a43
Notes These authors contributed equally to this work.
Conflict of Interest: The authors declare no conflicts of interest.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22640
PMID 25645694
PQID 1667347959
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4670699
proquest_miscellaneous_1673381757
proquest_miscellaneous_1667347959
pubmed_primary_25645694
crossref_primary_10_1002_cyto_a_22640
crossref_citationtrail_10_1002_cyto_a_22640
wiley_primary_10_1002_cyto_a_22640_CYTOA22640
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2015
PublicationDateYYYYMMDD 2015-04-01
PublicationDate_xml – month: 04
  year: 2015
  text: April 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chichester, UK
PublicationTitle Cytometry. Part A
PublicationTitleAlternate Cytometry A
PublicationYear 2015
Publisher John Wiley & Sons, Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
References 2006; 3
2011; 12
2011; 6
2012; 33
2013; 62
2011; 332
2012; 81A
2012; 30
2004; 45
2014; 377
e_1_2_5_9_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_7_1
e_1_2_5_6_1
e_1_2_5_5_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
Zivanovic N (e_1_2_5_10_1) 2014; 377
22902532 - Nat Biotechnol. 2012 Sep;30(9):858-67
15101706 - Leuk Lymphoma. 2004 Feb;45(2):229-36
21551058 - Science. 2011 May 6;332(6030):687-96
21955116 - Biomacromolecules. 2011 Nov 14;12(11):3997-4010
23918170 - Curr Top Microbiol Immunol. 2014;377:95-109
22539147 - Cytometry A. 2012 Jul;81(7):567-75
16628206 - Nat Methods. 2006 May;3(5):361-8
23564178 - Cancer Immunol Immunother. 2013 May;62(5):955-65
22476049 - Trends Immunol. 2012 Jul;33(7):323-32
21207359 - Curr Protoc Cytom. 2011 Jan;Chapter 6:Unit 6.31
References_xml – volume: 30
  start-page: 858
  year: 2012
  end-page: 867
  article-title: Multiplexed mass cytometry profiling of cellular states perturbed by small‐molecule regulators
  publication-title: Nat Biotechnol
– volume: 45
  start-page: 229
  year: 2004
  end-page: 236
  article-title: The biology of CD45 and its use as a therapeutic target
  publication-title: Leuk Lymphoma
– volume: 81A
  start-page: 567
  year: 2012
  end-page: 575
  article-title: Human CD4+ lymphocytes for antigen quantification: Characterization using conventional flow cytometry and mass cytometry
  publication-title: Cytometry A
– volume: 377
  start-page: 95
  year: 2014
  end-page: 109
  article-title: A practical guide to multiplexed mass cytometry
  publication-title: Curr Top Microbiol Immunol
– volume: 33
  start-page: 323
  year: 2012
  end-page: 332
  article-title: A deep profiler's guide to cytometry
  publication-title: Trends Immunol
– volume: 332
  start-page: 687
  year: 2011
  end-page: 696
  article-title: Single‐cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum
  publication-title: Science
– volume: 62
  start-page: 955
  year: 2013
  end-page: 965
  article-title: An introduction to mass cytometry: Fundamentals and applications
  publication-title: Cancer Immunol Immunother
– volume: 12
  start-page: 3997
  year: 2011
  end-page: 4010
  article-title: Curious results with Palladium‐ and Platinum‐carrying polymers in mass cytometry bioassays and an unexpected application as a dead cell stain
  publication-title: Biomarcomolecules
– volume: 6
  year: 2011
  article-title: Fluorescent cell barcoding for multiplex flow cytometry
  publication-title: Curr Protoc Cytom
– volume: 3
  start-page: 361
  year: 2006
  end-page: 368
  article-title: Fluorescent cell barcoding in flow cytometry allows high‐throughput drug screening and signaling profiling
  publication-title: Nat Methods
– ident: e_1_2_5_2_1
  doi: 10.1016/j.it.2012.02.010
– ident: e_1_2_5_5_1
  doi: 10.1038/nmeth872
– ident: e_1_2_5_7_1
  doi: 10.1002/cyto.a.22060
– ident: e_1_2_5_8_1
  doi: 10.1038/nbt.2317
– ident: e_1_2_5_3_1
  doi: 10.1007/s00262-013-1416-8
– ident: e_1_2_5_11_1
  doi: 10.1021/bm201011t
– ident: e_1_2_5_4_1
  doi: 10.1002/0471142956.cy0631s55
– volume: 377
  start-page: 95
  year: 2014
  ident: e_1_2_5_10_1
  article-title: A practical guide to multiplexed mass cytometry
  publication-title: Curr Top Microbiol Immunol
– ident: e_1_2_5_6_1
  doi: 10.1126/science.1198704
– ident: e_1_2_5_9_1
  doi: 10.1080/1042819031000151932
– reference: 21207359 - Curr Protoc Cytom. 2011 Jan;Chapter 6:Unit 6.31
– reference: 23564178 - Cancer Immunol Immunother. 2013 May;62(5):955-65
– reference: 21551058 - Science. 2011 May 6;332(6030):687-96
– reference: 21955116 - Biomacromolecules. 2011 Nov 14;12(11):3997-4010
– reference: 22902532 - Nat Biotechnol. 2012 Sep;30(9):858-67
– reference: 23918170 - Curr Top Microbiol Immunol. 2014;377:95-109
– reference: 15101706 - Leuk Lymphoma. 2004 Feb;45(2):229-36
– reference: 22539147 - Cytometry A. 2012 Jul;81(7):567-75
– reference: 16628206 - Nat Methods. 2006 May;3(5):361-8
– reference: 22476049 - Trends Immunol. 2012 Jul;33(7):323-32
SSID ssj0035032
Score 2.374625
Snippet CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 369
SubjectTerms Adult
Antibodies - immunology
barcoding
CD45
CyTOF
Flow Cytometry - methods
Humans
Leukocyte Common Antigens - analysis
Leukocyte Common Antigens - immunology
Leukocytes, Mononuclear - cytology
Mass Spectrometry - methods
multiplexing
Staining and Labeling
Technical Note
Title A CD45‐based barcoding approach to multiplex mass‐cytometry (CyTOF)
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.22640
https://www.ncbi.nlm.nih.gov/pubmed/25645694
https://www.proquest.com/docview/1667347959
https://www.proquest.com/docview/1673381757
https://pubmed.ncbi.nlm.nih.gov/PMC4670699
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dSxwxFL1UoeCL1Vp1a5UUWlBk1mwmk908LttupVAtsoI-hXwNSutM0Vno9qk_ob-xv6S581W3UkHfBuaGTCb3zj3J3JwD8EZLZ0RILZFDPkQuWPgOpjSOBpZ5SrUN6zfc7_h0JA5P-cez5KzecMOzMBU_RLvhhpFRfq8xwLW5OfhLGmpnRd7VXTwIikt2LNdCTHTSskfFCS31yZBkLOKSsbruPTQ_uN14PiPdgZl3qyVvo9gyDY2fgWoGUFWffOlOC9O1P_7hdnz8CFdguUaoZFi51Co88dlzeFppVs7W4MOQjN7x5PfPX5gAHTEhUnJMgKShJydFTpo6xe_kKqDzYIy9XPniekZ2R7PJ8XjvBZyO309Gh1GtxhDZhA3CGpNaG0tLmXfCamECtEldYnoypXpgPNMOz8wKLuLYCS0cNwY1w6XpIceR5vE6LGZ55jeBWGMNja2j_dRyrVMtvBTS8VSmzAQn6cB-MyPK1lTlqJjxVVUky0zhQyutylfTgbet9beKouM_dq-byVUhhvDHiM58Pr1RPdQ-5ai6fp9NP0Y2w6TfgY3KIdreGFLyCMk70J9zldYAObzn72SXFyWXd8hTVMjQb1R6wr0DUKPzyfGwvHz5QPstWApIL6lKjl7BYnE99dsBTRVmBxYY_7xTRs4fNV0fXw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZbxMxEB6hIgQv3Ecoh5FAAqFNHa_XiR-jQAjQQ0KpVJ5cXysQ7W5VNlLDEz-B38gvweM9aKiohHhbacfyej3jmbHH3wfwVEtnRHAtiUM8RC5YWAdzmiYjyzyl2ob8Dfc7trbFbJe_28v2Gp5TvAtT40N0G25oGXG9RgPHDemN36ihdlmVfd3Hm6AhZ7-IpN4xp_rQ4UelGY0MZQgzlnDJWFP5HtpvnG696pPOBJpn6yVPx7HREU2vwX47hLr-5Et_UZm-_fYHuuN_jPE6XG2CVDKuteoGXPDFTbhU01Yub8GbMZm84tnP7z_QBzpigrGU6ANJi1BOqpK0pYon5DAE6EEYezn01fGSPJ8s5zvTF7dhd_p6PpklDSFDYjM2CmkmtTaVljLvhNXChOgmd5kZyJzqkfFMO7w2K7hIUye0cNwYpA2XZoAwR5qnd2CtKAt_D4g11tDUOjrMLdc618JLIR3PZc5M0JMevGynRNkGrRxJMw5UjbPMFH600ir-mh4866SPapSOv8g9aWdXBTPCsxFd-HLxVQ2Q_pQj8fp5MsMUAQ2zYQ_u1hrR9cYQlUdI3oPhiq50Agjjvfqm-PwpwnkHV0WFDP0mURXOHYCafJzvjOPj_X-UfwyXZ_OtTbX5dvv9OlwJgV9WVyA9gLXqeOEfhuCqMo-iAf0CPB4iow
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9QwEICtqqiIC1CeW9piJJBAKFuv43jXx9Vul_JqEdpK7cnyKwLRJlXJSt2e-hP4jfwSZvKiS0UluEXKWI7jmczYGX9DyHOjvJXgWiKPPEQhOXwHUxZHA8cDY8bB-g33Oz7uyp198e4gOag33PAsTMWHaDfc0DLK7zUa-IlPt35DQ928yLumiwdBYcl-Q0CPqNXjzy0-Kk5YWaAMKWORUJzXie_Qfuty60WXdCXOvJoueTmMLf3Q5A7RzQiq9JNv3Vlhu-78D7jj_w_xLrldh6h0WOnUKlkK2T2yUhWtnN8nb4Z0NBbJz4sf6AE9tWAqOXpA2vDJaZHTJlHxjB5DeA7C2MtxKE7n9OVoPt2bvHpA9ifb09FOVJdjiFzCB7DIZM7FyjEevHRGWohtUp_YnkqZGdjAjcdDs1LIOPbSSC-sxaLhyvYQcmRE_JAsZ3kWHhPqrLMsdp71UyeMSY0MSiovUpVyC1rSIa-bGdGuZpVjyYwjXVGWucaH1kaXr6ZDXrTSJxWj4y9yz5rJ1WBE-GfEZCGffdc9LH4qsOz6dTL9GHGGSb9DHlUK0fbGkckjleiQ_oKqtAII8V68k339UsK8wVExqaDfqNSEawegR4fTvWF5ufaP8k_JzU_jif7wdvf9E3ILor6kSj9aJ8vF6SxsQGRV2M3SfH4B5zshWw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+CD45-based+barcoding+approach+to+multiplex+mass-cytometry+%28CyTOF%29&rft.jtitle=Cytometry.+Part+A&rft.au=Lai%2C+Liyun&rft.au=Ong%2C+Raymond&rft.au=Li%2C+Juntao&rft.au=Albani%2C+Salvatore&rft.date=2015-04-01&rft.issn=1552-4930&rft.eissn=1552-4930&rft.volume=87&rft.issue=4&rft.spage=369&rft_id=info:doi/10.1002%2Fcyto.a.22640&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon